Healthcare

Healius Limited (ASX:HLS) has reported its FY2026 results, highlighting growth in underlying earnings, cost management initiatives, digital investments and progress under its T27 transformation plan.

AVITA Medical, Inc. (NASDAQ:RCEL) (ASX:AVH) has reported positive results from the PermeaDerm-I multicentre randomized controlled clinical study, with the biosynthetic wound matrix demonstrating a lower treatment cost than cadaveric allograft while producing comparable reported clinical outcomes.

EBOS Group (ASX:EBO) reported higher revenue and Underlying EBITDA for the financial year ended 30 June 2026, although Underlying NPAT declined as the cost of its recent investment program continued to affect earnings. Revenue increased 9.9% to $13.5 billion from $12.3 billion, while Underlying …

For income-focused investors who bought HCW as a defensive healthcareYieldplay, that is the sting in an otherwise steadier update. Rent is being collected, occupancy is near full, and theBalance Sheetis conservatively geared. But the payout that once defined the stock remains switched off until …

For a company that spent much of the past year as one of the ASX's most spectacular fallers, a profit decline greeted by a share-price jump marks a notable shift in tone. The question now is whether this is the start of a genuine …

CSL released its full-year results for the 12 months ended 30 June 2026 before the market opened on 18 August. The reported net result was a loss of about US$2.6 billion attributable to shareholders, a starkReversalfrom the roughly US$3.0 billion profit posted in FY25.

OncoSil Medical Ltd (ASX:OSL) closed at AUD 1.150 on 18 August 2026, declining AUD 0.049 or 4.166% from the previous close of AUD 1.200. The shares traded between AUD 1.100 and AUD 1.190 during the session, withVolumeof 321,014 shares.